Characterization of Incidental Liver Lesions: Comparison of Multidetector CT versus Ultrasonography

ORIGINAL ARTICLE
Hanady Elyas Osman

 
International Journal of Biomedicine. 2023;13(1):84-90.
DOI: 10.21103/Article13(1)_OA10
Originally published March 3, 2023

Abstract: 

Background: Due to recent advancements in imaging techniques, as well as the widespread use of routine medical exams and screenings, incidental LL are now more frequently discovered by US. Physicians must decide whether to simply follow up when incidental LL are discovered in the US or to order additional imaging tests for lesion classification. The goal of our study was to identify LL using MDCT and US.
Methods and Results: A total of 50 participants were selected from a variety of male and female patients with abdominal pain and suspected liver diseases, and received a CT triphasic scan and US at the Royal Care International Hospital, Ibn Alhaitham Diagnostic Center, Alfaisal Specialized Hospital, and the Department of Diagnostic Radiology in the CT department of Sudan from April 2018 to May 2020.
The results of the ultrasound scanning (liver lesions and related findings) performed on patients before the CT scanning indicated that ascites+ liver lesions was predominant (48.6%). The incidental liver lesions that take peripheral nodular enhancement by MDCT when contrast media is injected, were liver metastases (30%), hemangioma (14%), and HCC (10%). Liver cysts represent 10(20%) of the total cases of lesions that were non-enhanced by CT, with a few cases of liver cirrhosis (2%), hepatosplenomegaly (2%), and cyst + hepatitis (2%). We found a significant relationship between peripheral nodular enhancement for liver lesions by MDCT and non-enhancing liver lesions (P=0.001).
Conclusion: The US and CT scan findings have a statistically significant relationship (P≤0.017). Contrast-enhanced CT performs better at diagnosing liver lesions than does standard US.

Keywords: 
liver lesions • multidetector computed tomography • ultrasonography • nodular enhancement • contrast-enhanced computed tomography
References: 
  1. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology. 1999 Jan;210(1):71-4. doi: 10.1148/radiology.210.1.r99ja0371.
  2. Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology. 2005 Jun;235(3):872-8. doi: 10.1148/radiol.2353041099. 
  3. Wilson SR, Jang HJ, Kim TK, Burns PN. Diagnosis of focal liver masses on ultrasonography: comparison of unenhanced and contrast-enhanced scans. J Ultrasound Med. 2007 Jun;26(6):775-87; quiz 788-90. doi: 10.7863/jum.2007.26.6.775. 
  4. Furuta A, Ito K, Fujita T, Koike S, Shimizu A, Matsunaga N. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. AJR Am J Roentgenol. 2004 Jul;183(1):157-62. doi: 10.2214/ajr.183.1.1830157. 
  5. Adam A, Dixon AK, Gillard JH, Schaefer-Prokop C, Grainger RG, Allison DJ. Grainger & Allison's Diagnostic Radiology E-Book. Elsevier Health Sciences; 2014 Jun 16.
  6. Rumack CM, Wilson SR, Charboneau JW. Diagnostic Ultrasound Volume 1. 3rd Edition, Elsevier Mosby, Philadelphia; 2005.
  7. Kulinna C, Schima W. Imaging Features of Hepatic Metastases: CT and MR. In: Lencioni, R., Cioni, D., Bartolozzi, C. (Eds) Focal Liver Lesions. Medical Radiology. Springer, Berlin, Heidelberg; 2005.
  8. Iannaccone R, Piacentini F, Murakami T, Paradis V, Belghiti J, Hori M, Kim T, Durand F, Wakasa K, Monden M, Nakamura H, Passariello R, Vilgrain V. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology. 2007 May;243(2):422-30. doi: 10.1148/radiol.2432051244. 
  9. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, Liang JY. Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients. J Ultrasound Med. 2006 Mar;25(3):349-61. doi: 10.7863/jum.2006.25.3.349. 
  10. Soyer P, Sirol M, Fargeaudou Y, Duchat F, Hamzi L, Boudiaf M, Aout M, Guerrache Y, Vicaut E, Rymer R. Differentiation between true focal liver lesions and pseudolesions in patients with fatty liver: evaluation of helical CT criteria. Eur Radiol. 2010 Jul;20(7):1726-37. doi: 10.1007/s00330-009-1708-8. 
  11. Davarpanah AH, Weinreb JC. The role of imaging in hepatocellular carcinoma: the present and future. J Clin Gastroenterol. 2013 Jul;47 Suppl:S7-10. doi: 10.1097/MCG.0b013e31827f0d3d.
  12. Kar P., Rajat J. Imaging of Space Occupying Lesions of Liver. Medicine Update -2011. Available from: https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=255509ad2...
  13. Butt AS, Hamid S, Wadalawala AA, Ghufran M, Javed AA, Farooq O, Ahmed B, Ul Haq T, Jafri W. Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma. BMC Res Notes. 2013 Apr 8;6:137. doi: 10.1186/1756-0500-6-137. 
  14. Robison JG, Pollock TW. Computed tomography in the diagnosis and localization of intraabdominal abscesses. Am J Surg. 1980 Dec;140(6):783-6. doi: 10.1016/0002-9610(80)90117-8.
  15. Senturk S, Cetin B, Cengiz M, Bilici A, Ozekinci S. Dynamic multidetector computed tomography findings of hepatocellular carcinoma of hepatitis B virus-positive and -negative patients. Cancer Imaging. 2014 Apr 22;14(1):9. doi: 10.1186/1470-7330-14-9.

Download Article
Received November 28, 2022.
Accepted January 2, 2023.
©2023 International Medical Research and Development Corporation.